Evidence for the existence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with and without abdominal discomfort (irritable bowel) syndrome.
Identifieur interne : 002027 ( Ncbi/Merge ); précédent : 002026; suivant : 002028Evidence for the existence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with and without abdominal discomfort (irritable bowel) syndrome.
Auteurs : Michael Maes [Thaïlande] ; Jean-Claude Leunis [Belgique] ; Michel Geffard [France] ; Michael Berk [Australie]Source :
- Neuro endocrinology letters [ 0172-780X ] ; 2014.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Analyse de regroupements, Anticorps antibactériens (sang), Femelle, Humains, Immunoglobuline A (sang), Immunoglobuline M (sang), Lipopolysaccharides (immunologie), Mâle, Syndrome de fatigue chronique (), Syndrome de fatigue chronique (immunologie), Syndrome de fatigue chronique (microbiologie), Syndrome du côlon irritable (), Syndrome du côlon irritable (immunologie), Syndrome du côlon irritable (microbiologie), Translocation bactérienne (immunologie).
- MESH :
- immunologie : Lipopolysaccharides, Syndrome de fatigue chronique, Syndrome du côlon irritable, Translocation bactérienne.
- microbiologie : Syndrome de fatigue chronique, Syndrome du côlon irritable.
- sang : Anticorps antibactériens, Immunoglobuline A, Immunoglobuline M.
- Adulte, Adulte d'âge moyen, Analyse de regroupements, Femelle, Humains, Mâle, Syndrome de fatigue chronique, Syndrome du côlon irritable.
English descriptors
- KwdEn :
- Adult, Antibodies, Bacterial (blood), Bacterial Translocation (immunology), Cluster Analysis, Fatigue Syndrome, Chronic (complications), Fatigue Syndrome, Chronic (immunology), Fatigue Syndrome, Chronic (microbiology), Female, Humans, Immunoglobulin A (blood), Immunoglobulin M (blood), Irritable Bowel Syndrome (complications), Irritable Bowel Syndrome (immunology), Irritable Bowel Syndrome (microbiology), Lipopolysaccharides (immunology), Male, Middle Aged.
- MESH :
- chemical , blood : Antibodies, Bacterial, Immunoglobulin A, Immunoglobulin M.
- complications : Fatigue Syndrome, Chronic, Irritable Bowel Syndrome.
- immunology : Bacterial Translocation, Fatigue Syndrome, Chronic, Irritable Bowel Syndrome, Lipopolysaccharides.
- microbiology : Fatigue Syndrome, Chronic, Irritable Bowel Syndrome.
- Adult, Cluster Analysis, Female, Humans, Male, Middle Aged.
Abstract
There is evidence that Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is accompanied by gastro-intestinal symptoms; and IgA and IgM responses directed against lipopolysaccharides (LPS) of commensal bacteria, indicating bacterial translocation.
PubMed: 25433843
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003A17
- to stream PubMed, to step Curation: 003893
- to stream PubMed, to step Checkpoint: 003893
Links to Exploration step
pubmed:25433843Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Evidence for the existence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with and without abdominal discomfort (irritable bowel) syndrome.</title><author><name sortKey="Maes, Michael" sort="Maes, Michael" uniqKey="Maes M" first="Michael" last="Maes">Michael Maes</name><affiliation wicri:level="1"><nlm:affiliation>Maes Clinics @ TRIA, Bangkok, Thailand, Thailand.</nlm:affiliation><country xml:lang="fr">Thaïlande</country><wicri:regionArea>Maes Clinics @ TRIA, Bangkok, Thailand</wicri:regionArea><wicri:noRegion>Thailand</wicri:noRegion></affiliation></author><author><name sortKey="Leunis, Jean Claude" sort="Leunis, Jean Claude" uniqKey="Leunis J" first="Jean-Claude" last="Leunis">Jean-Claude Leunis</name><affiliation wicri:level="1"><nlm:affiliation>Laboratory Ategis, Wavre, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Laboratory Ategis, Wavre</wicri:regionArea><wicri:noRegion>Wavre</wicri:noRegion></affiliation></author><author><name sortKey="Geffard, Michel" sort="Geffard, Michel" uniqKey="Geffard M" first="Michel" last="Geffard">Michel Geffard</name><affiliation wicri:level="3"><nlm:affiliation>Association Institute for Research and Development in Human Pathology and Therapy, Talence, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Association Institute for Research and Development in Human Pathology and Therapy, Talence</wicri:regionArea><placeName><region type="region" nuts="2">Aquitaine-Limousin-Poitou-Charentes</region><region type="old region" nuts="2">Aquitaine</region><settlement type="city">Talence</settlement><settlement type="city" wicri:auto="agglo">Bordeaux</settlement></placeName></affiliation></author><author><name sortKey="Berk, Michael" sort="Berk, Michael" uniqKey="Berk M" first="Michael" last="Berk">Michael Berk</name><affiliation wicri:level="1"><nlm:affiliation>Department of Psychiatry, Deakin University, Geelong, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Psychiatry, Deakin University, Geelong</wicri:regionArea><wicri:noRegion>Geelong</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:25433843</idno><idno type="pmid">25433843</idno><idno type="wicri:Area/PubMed/Corpus">003A17</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003A17</idno><idno type="wicri:Area/PubMed/Curation">003893</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003893</idno><idno type="wicri:Area/PubMed/Checkpoint">003893</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003893</idno><idno type="wicri:Area/Ncbi/Merge">002027</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Evidence for the existence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with and without abdominal discomfort (irritable bowel) syndrome.</title><author><name sortKey="Maes, Michael" sort="Maes, Michael" uniqKey="Maes M" first="Michael" last="Maes">Michael Maes</name><affiliation wicri:level="1"><nlm:affiliation>Maes Clinics @ TRIA, Bangkok, Thailand, Thailand.</nlm:affiliation><country xml:lang="fr">Thaïlande</country><wicri:regionArea>Maes Clinics @ TRIA, Bangkok, Thailand</wicri:regionArea><wicri:noRegion>Thailand</wicri:noRegion></affiliation></author><author><name sortKey="Leunis, Jean Claude" sort="Leunis, Jean Claude" uniqKey="Leunis J" first="Jean-Claude" last="Leunis">Jean-Claude Leunis</name><affiliation wicri:level="1"><nlm:affiliation>Laboratory Ategis, Wavre, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Laboratory Ategis, Wavre</wicri:regionArea><wicri:noRegion>Wavre</wicri:noRegion></affiliation></author><author><name sortKey="Geffard, Michel" sort="Geffard, Michel" uniqKey="Geffard M" first="Michel" last="Geffard">Michel Geffard</name><affiliation wicri:level="3"><nlm:affiliation>Association Institute for Research and Development in Human Pathology and Therapy, Talence, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Association Institute for Research and Development in Human Pathology and Therapy, Talence</wicri:regionArea><placeName><region type="region" nuts="2">Aquitaine-Limousin-Poitou-Charentes</region><region type="old region" nuts="2">Aquitaine</region><settlement type="city">Talence</settlement><settlement type="city" wicri:auto="agglo">Bordeaux</settlement></placeName></affiliation></author><author><name sortKey="Berk, Michael" sort="Berk, Michael" uniqKey="Berk M" first="Michael" last="Berk">Michael Berk</name><affiliation wicri:level="1"><nlm:affiliation>Department of Psychiatry, Deakin University, Geelong, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Psychiatry, Deakin University, Geelong</wicri:regionArea><wicri:noRegion>Geelong</wicri:noRegion></affiliation></author></analytic><series><title level="j">Neuro endocrinology letters</title><idno type="ISSN">0172-780X</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Antibodies, Bacterial (blood)</term><term>Bacterial Translocation (immunology)</term><term>Cluster Analysis</term><term>Fatigue Syndrome, Chronic (complications)</term><term>Fatigue Syndrome, Chronic (immunology)</term><term>Fatigue Syndrome, Chronic (microbiology)</term><term>Female</term><term>Humans</term><term>Immunoglobulin A (blood)</term><term>Immunoglobulin M (blood)</term><term>Irritable Bowel Syndrome (complications)</term><term>Irritable Bowel Syndrome (immunology)</term><term>Irritable Bowel Syndrome (microbiology)</term><term>Lipopolysaccharides (immunology)</term><term>Male</term><term>Middle Aged</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Analyse de regroupements</term><term>Anticorps antibactériens (sang)</term><term>Femelle</term><term>Humains</term><term>Immunoglobuline A (sang)</term><term>Immunoglobuline M (sang)</term><term>Lipopolysaccharides (immunologie)</term><term>Mâle</term><term>Syndrome de fatigue chronique ()</term><term>Syndrome de fatigue chronique (immunologie)</term><term>Syndrome de fatigue chronique (microbiologie)</term><term>Syndrome du côlon irritable ()</term><term>Syndrome du côlon irritable (immunologie)</term><term>Syndrome du côlon irritable (microbiologie)</term><term>Translocation bactérienne (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Bacterial</term><term>Immunoglobulin A</term><term>Immunoglobulin M</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Fatigue Syndrome, Chronic</term><term>Irritable Bowel Syndrome</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Lipopolysaccharides</term><term>Syndrome de fatigue chronique</term><term>Syndrome du côlon irritable</term><term>Translocation bactérienne</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Bacterial Translocation</term><term>Fatigue Syndrome, Chronic</term><term>Irritable Bowel Syndrome</term><term>Lipopolysaccharides</term></keywords><keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Syndrome de fatigue chronique</term><term>Syndrome du côlon irritable</term></keywords><keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Fatigue Syndrome, Chronic</term><term>Irritable Bowel Syndrome</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antibactériens</term><term>Immunoglobuline A</term><term>Immunoglobuline M</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Cluster Analysis</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Analyse de regroupements</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Syndrome de fatigue chronique</term><term>Syndrome du côlon irritable</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">There is evidence that Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is accompanied by gastro-intestinal symptoms; and IgA and IgM responses directed against lipopolysaccharides (LPS) of commensal bacteria, indicating bacterial translocation.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25433843</PMID><DateCreated><Year>2015</Year><Month>01</Month><Day>25</Day></DateCreated><DateCompleted><Year>2015</Year><Month>03</Month><Day>10</Day></DateCompleted><DateRevised><Year>2015</Year><Month>01</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0172-780X</ISSN><JournalIssue CitedMedium="Print"><Volume>35</Volume><Issue>6</Issue><PubDate><Year>2014</Year></PubDate></JournalIssue><Title>Neuro endocrinology letters</Title><ISOAbbreviation>Neuro Endocrinol. Lett.</ISOAbbreviation></Journal><ArticleTitle>Evidence for the existence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with and without abdominal discomfort (irritable bowel) syndrome.</ArticleTitle><Pagination><MedlinePgn>445-53</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There is evidence that Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is accompanied by gastro-intestinal symptoms; and IgA and IgM responses directed against lipopolysaccharides (LPS) of commensal bacteria, indicating bacterial translocation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This study was carried out to examine gastro-intestinal symptoms in subjects with ME/CFS versus those with chronic fatigue (CF). The two groups were dissected by dichotomizing those fulfilling and not fulfilling Fukuda's critera. In these groups, we examined the association between gastro-intestinal symptoms and the IgA and IgM responses directed against commensal bacteria.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Using cluster analysis performed on gastro-intestinal symptoms we delineated that the cluster analysis-generated diagnosis of abdominal discomfort syndrome (ADS) was significantly higher in subjects with ME/CFS (59.6%) than in those with CF (17.7%). The diagnosis of ADS was strongly associated with the diagnosis of irritable bowel syndrome (IBS). There is evidence that ME/CFS consists of two subgroups, i.e. ME/CFS with and without ADS. Factor analysis showed four factors, i.e. 1) inflammation-hyperalgesia; 2) fatigue-malaise; 3) gastro-intestinal symptoms/ADS; and 4) neurocognitive symptoms. The IgA and IgM responses to LPS of commensal bacteria were significantly higher in ME/CFS patients with ADS than in those without ADS.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The findings show that ADS is a characteristic of a subset of patients with ME/CFS and that increased bacterial translocation (leaky gut) is associated with ADS symptoms. This study has defined a pathway phenotype, i.e bacterial translocation, that is related to ME/CFS and ADS/IBS and that may drive systemic inflammatory processes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maes</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Maes Clinics @ TRIA, Bangkok, Thailand, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leunis</LastName><ForeName>Jean-Claude</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Laboratory Ategis, Wavre, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geffard</LastName><ForeName>Michel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Association Institute for Research and Development in Human Pathology and Therapy, Talence, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berk</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Deakin University, Geelong, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Sweden</Country><MedlineTA>Neuro Endocrinol Lett</MedlineTA><NlmUniqueID>8008373</NlmUniqueID><ISSNLinking>0172-780X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000907">Antibodies, Bacterial</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007070">Immunoglobulin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007075">Immunoglobulin M</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000907" MajorTopicYN="N">Antibodies, Bacterial</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018988" MajorTopicYN="N">Bacterial Translocation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007070" MajorTopicYN="N">Immunoglobulin A</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007075" MajorTopicYN="N">Immunoglobulin M</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D043183" MajorTopicYN="Y">Irritable Bowel Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008070" MajorTopicYN="N">Lipopolysaccharides</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>09</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>09</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25433843</ArticleId><ArticleId IdType="pii">NEL350614A01</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Australie</li><li>Belgique</li><li>France</li><li>Thaïlande</li></country><region><li>Aquitaine</li><li>Aquitaine-Limousin-Poitou-Charentes</li></region><settlement><li>Bordeaux</li><li>Talence</li></settlement></list><tree><country name="Thaïlande"><noRegion><name sortKey="Maes, Michael" sort="Maes, Michael" uniqKey="Maes M" first="Michael" last="Maes">Michael Maes</name></noRegion></country><country name="Belgique"><noRegion><name sortKey="Leunis, Jean Claude" sort="Leunis, Jean Claude" uniqKey="Leunis J" first="Jean-Claude" last="Leunis">Jean-Claude Leunis</name></noRegion></country><country name="France"><region name="Aquitaine-Limousin-Poitou-Charentes"><name sortKey="Geffard, Michel" sort="Geffard, Michel" uniqKey="Geffard M" first="Michel" last="Geffard">Michel Geffard</name></region></country><country name="Australie"><noRegion><name sortKey="Berk, Michael" sort="Berk, Michael" uniqKey="Berk M" first="Michael" last="Berk">Michael Berk</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002027 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 002027 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:25433843
|texte= Evidence for the existence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with and without abdominal discomfort (irritable bowel) syndrome.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:25433843" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |